Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

OpenAI is rolling out access to the viral Sora 2 app for users in the US, Canada, Japan and South Korea, but only for a limited time. Katelyn is a writer with CNET covering artificial intelligence, ...

Creating prequels of popular shows can be like navigating a minefield. Will the existing audience connect with the story? Are you risking interfering with canon by inventing new scenarios, especially ...

I've been testing OpenAI's upgraded AI video generator and have figured out how to get the best results. I’ve been writing about consumer technology and video games for more than a decade at a variety ...

The biggest part of being a vampire in Vampire: The Masquerade — Bloodlines 2 is not breaking the Masquerade, while also getting some blood for yourself. Luckily, you can easily do that in the streets ...

When you track a strength training workout on a fitness watch, that watch will happily tell you what heart rate zones you were in during the workout. In fact, they'll do that for any workout, whether ...

NCsoft announced that it will open its first global project 'Samurai Crow' on November 5 at MMORPG 'Lineage 2'. To this end, new servers and new classes 'crow' will be updated simultaneously in ...

Kristian Campbell's season was filled with ups and downs. Winslow Townson / Getty Images After an eventful season for Kristian Campbell — making his big league debut, signing a multi-million dollar ...

The Apple Watch’s hypertension notifications may soon have a competitor. Oura, maker of smart rings, is planning to pursue FDA clearance for their own warning feature for high blood pressure. Oura ...

Novo Nordisk NOVO.B2.49%increase; green up pointing triangle said it would take over a drug under development to treat rare blood and kidney disorders from Nasdaq-listed biopharmaceutical firm Omeros ...